The Court has approved the distribution of the net settlement fund to eligible Court-approved Claimants who qualified for an award under the Plan of Allocation. Alabama has had among the highest rates of opioid prescriptions distributed and has fought to hold the companies involved accountable for the widespread damage caused by the addiction epidemic. A court filing made Tuesday, Feb. 1, 2022 in Cleveland lays out the details of the settlements with. Alabama settles opioid claims with J&J, McKesson, Endo for $276 million Court-appointed Lead Plaintiff SEB Investment Management AB, on behalf of itself and the Settlement Class, reached a settlement of the Action withDefendants for $82,500,000 in cash ("Settlement"). Community Rules apply to all content you upload or otherwise submit to this site. Endo Announces Execution of Definitive Settlement Agreement and Release 12th floor The information contained on this website is only a summary of the information presented in more detail in the Notice of (I) Pendency of Class Action and Proposed Settlement; (II) Motion for an Award of Attorneys' Fees and Reimbursement of Litigation Expenses; and (III) Settlement Fairness Hearing ("Notice"). by Endo Pharmaceutical: The State of Alabama and its subdivisions will receive $25 million this year in a lump-sum payment. Attorney General James Secures $50 Million for Opioid Abatement from Attorney General Marshall affirmed his prior decision to not participate in the national opioid settlements, saying, These three settlement agreements affirm my decision to decline participation in the national opioid settlements, which did not adequately acknowledge the unique harm that Alabamians have endured and would have redirected millions of dollars to bigger states that experienced a less severe impact.. Endo, in an October filing, said that Alabama was seeking at least $10 billion to abate the epidemic and public nuisance the state argued [it] created, as well as $1.65 billion in damages stemming for diminished income and sales tax revenues.. He can be reached at brendan.pierson@thomsonreuters.com. We envisioned and developed a State plan long before there was any funding to make it a reality, and I am pleased that we can finally put our plan to good use.. . The company has said it is considering "strategic alternatives" if it cannot reach a global settlement, and plaintiffs have raised the possibility of Endo filing for bankruptcy. Defendants deny all allegations of wrongdoing or liability whatsoever. Brendan Pierson reports on product liability litigation and on all areas of health care law.
Alabama will spend nearly one-third of the $9 million opioid crisis settlement money with McKinsey & Company, on investments in the state's forensic labs, according to the attorney general's office. disclosure was made in a court filing by McKesson Corp. (. J&J, Endo and McKesson settle Alabama opioid litigation for $276M The settlement and ongoing negotiations were revealed in a filing Sunday in Montgomery County Circuit Court by McKesson. These discussions have put a hold on a full-blown trial against (what originally had been) both parties. 501 Washington Avenue
Under the Endo settlement, Alabama will receive the $25 million in a lump-sum payment. If you have any questions regarding the distribution, please contact JND by calling 844-961-0316 or by sending an e-mail to Info@EndoSecuritiesLitigationSettlement.com. A spokesperson for Marshall, a Republican, previously told Reuters that the state opted out of the deal "to pursue its own legal strategy to best address the impact of the opioid crisis on Alabama.". The state is one of eight that opted to not settle with McKesson, who along with rivals AmerisourceBergen and Cardinal Health agreed in July to pay $21 billion to resolve thousands of opioid lawsuits by other states and local governments. v. Endo International (Lidoderm) Settlement. The filing indicates that the company and the state are negotiating a settlement as well. Settlement Endo Pharmaceutical: The State of Alabama and its subdivisions will receive $25 million in 2022 in a lump-sum payment.By comparison, two similarly populated states and their subdivisions settled . This is the first multistate opioid settlement to result in substantial payment to the states to address the crisis. Native American tribes in the U.S. have reached settlements worth $590 million over opioids. The share of each settlement that goes toward the state government will be deposited into the States General Fund and the Alabama legislature will work to determine the best use of that funding. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookie Statement, and Your Privacy Choices and Rights (each updated 1/26/2023). Alabama to get $276 million settlement over opioid epidemic Gwengoat/iStock via Getty Images. Alabama settles opioid claims against Endo, in talks with McKesson Attorney General's Office - State of Alabama Reuters, the news and media division of Thomson Reuters, is the worlds largest multimedia news provider, reaching billions of people worldwide every day. The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. Be sure to reference where the error appears on the page and what needs to be done specifically. While Alabama would have received the same amount in the national settlement, it would have been paid out over nine years (not in one lump sum). To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser. Alabama was one of eight states that declined to join a proposed $26 billion settlement of opioid litigation nationwide by McKesson, two other distributors and the drugmaker Johnson & Johnson by a September deadline. In making that decision, they will be able to review the past two and a half years of work by the Alabama Opioid Overdose and Addiction Council to determine where they money is needed the most. All of the settlement funds are to be allocated towards remediating the harms caused by the opioid crisis in the state. By comparison, two similarly populated states and their subdivisions settled with Endo for 26% and 35% of the total that Alabama was able to secure. McKesson and Endo have denied any wrongdoing on their end. Wenn Sie Ihre Auswahl anpassen mchten, klicken Sie auf Datenschutzeinstellungen verwalten. The city will receive $110,953 minus a 25% fee that goes to attorneys from Endo Pharmaceuticals' settlement with the State of Alabama. Alabama et al. I am grateful to each member of the Alabama Opioid Overdose and Addiction Council who has put in the time and energy to provide our legislators with a roadmap as they make critical decisions about the use of this money. Alabama is not taking part in a $26 billion settlement to resolve lawsuits against drug companies over harm caused by addiction to opioids and will pursue its own case, Attorney General Steve. The three companies will also pay a combined $40 million in attorneys fees. Please. Two states with populations similar to Alabama settled with Endo for 26% and 35% of the total amount that Alabama was able to obtain. All rights reserved (About Us). Alabama AG Ends Opioid Holdout With Deals Worth $276M Instead, the state continues to pursue its own legal strategy to best address the impact of the opioid crisis on Alabama.. Please enter your change or describe your request. McKesson: The State of Alabama and its subdivisions will receive $141 million over nine years. For Alabama: Jere Beasley and Rhon Jones of Beasley, Allen, Crow, Methvin, Portis & Miles; and Robert Prince of Prince Glover Hayes, For McKesson: Harlan Prater of Lightfoot, Franklin & White; and H. Lewis Gillis of Means Gillis Law, For Endo: Carole Rendon of Baker & Hostetler, McKesson, Endo face multi-billion dollar opioid trial in Alabama, Drug companies say enough U.S. states join $26 bln opioid settlement to proceed. In addition to the funding for remediation, the state recovered approximately $40 million in attorneys fees and costs. Eighteen states reached a settlement with Endo Pharmaceuticals Inc. under which Endo paid $2.3 million to settle allegations it entered into a reverse-payment agreement to obstruct generic competition to Lidoderm, a pain relief patch frequently used to treat shingles. YouTubes privacy policy is available here and YouTubes terms of service is available here. Weitere Informationen ber die Verwendung Ihrer personenbezogenen Daten finden Sie in unserer Datenschutzerklrung und unserer Cookie-Richtlinie. The breakdown of the settlements are as follows: Endo Pharmaceutical: The State of Alabama and its subdivisions will receive $25 million this year in a lump-sum payment. The case is State of Alabama v. Endo Health Solutions Inc, Montgomery County Circuit Court, Alabama, No. The state is asking for civil penalties, restitution, and punitive damages. See here for a complete list of exchanges and delays. Online CME Program Updates Allergists, Dermatologists on New Therapeutic Strategies for Severe Atopic Dermatitis, Bausch Health Receives Untitled Letter from OPDP Over Statements Made on Morning Show, MATE Act Becomes Law: DEA Healthcare Provider License Holders Required to Complete 8. See here for a complete list of exchanges and delays. McKesson has the largest share of the settlement, paying $141 million while Johnson & Johnson agreed to pay $70.3 million, and Endo International agreed to pay $25 million.